Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Tirzepatide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Those qualifying conditions include type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, cardiovascular disease, polycystic ovary syndrome, and non-alcoholic fatty liver disease
It is useful in predicting outcome in thin tumours, and less useful for thicker ones in comparison to the value of the Breslow thickness
2.5 mg dose in a 12 mg vial: Target 50 units (0.5 mL)
When using compounded tirzepatide, you need to think ahead about how dose changes affect your vial usage